Molecular biology of medulloblastoma: Will it ever make a difference to clinical management?

Journal of Neuro-Oncology

Volumn 75, Issue 3, 2005, Pages 273-278

  Gilbertson, Richard J ^a   Gajjar, Amar ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

DNA; Gene; Medulloblastoma; Microarray; Molecular targeted therapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; LAPATINIB; LOMUSTINE;

ACCURACY; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DNA MICROARRAY; DRUG TARGETING; GENE AMPLIFICATION; GENE DELETION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; LUNG NON SMALL CELL CANCER; MEDULLOBLASTOMA; MOLECULAR BIOLOGY; PATIENT CARE; REVIEW; RISK ASSESSMENT;

ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; CEREBELLAR NEOPLASMS; CHILD; CLINICAL TRIALS; DNA, NEOPLASM; HUMANS; MEDULLOBLASTOMA; MOLECULAR BIOLOGY;

EID: 29644434598     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-6750-z     Document Type: Review

References (37)

1. RJ Gilbertson 2004 Medulloblastoma: Signalling a change in treatment Lancet Oncol 5 209-218 10.1016/S1470-2045(04)01424-X 15050952
2. JC Wasson RL Saylors 3rd P Zeltzer HS Friedman SH Bigner PC Burger DD Bigner AT Look EC Douglass GM Brodeur 1990 Oncogene amplification in pediatric brain tumors Cancer Res 50 2987-2990 2334901 1:CAS:528:DyaK3cXksFKmu7g%3D
3. PD Nisen KA Zimmerman SV Cotter F Gilbert FW Alt 1986 Enhanced expression of the N-myc gene in Wilms' tumors Cancer Res 46 6217-6222 2430692 1:CAS:528:DyaL2sXivVCitg%3D%3D
4. D Malkin FP Li LC Strong JF Fraumeni Jr. CE Nelson DH Kim J Kassel MA Gryka FZ Bischoff MA Tainsky et al 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1233-1238 1978757 1:CAS:528:DyaK3MXjslSisw%3D%3D
5. RL Saylors 3rd D Sidransky HS Friedman SH Bigner DD Bigner B Vogelstein GM Brodeur 1991 Infrequent p53 gene mutations in medulloblastomas Cancer Res 51 4721-4723 1873817
6. A Gajjar R Hernan M Kocak C Fuller Y Lee PJ McKinnon D Wallace C Lau M Chintagumpala DM Ashley SJ Kellie L Kun RJ Gilbertson 2004 Clinical, histopathologic, and molecular markers of prognosis: Toward a new disease risk stratification system for medulloblastoma J Clin Oncol 22 984-993 10.1200/JCO.2004.06.032 14970185 1:CAS:528:DC%2BD2cXptlCkurs%3D Epub 2004 Feb 2017
7. RJ Gilbertson RH Perry PJ Kelly AD Pearson J Lunec 1997 Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma Cancer Res 57 3272-3280 9242460 1:CAS:528:DyaK2sXkvFKqsbw%3D
8. MA Grotzer AJ Janss K Fung JA Biegel LN Sutton LB Rorke H Zhao A Cnaan PC Phillips VM Lee JQ Trojanowski 2000 TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors J Clin Oncol 18 1027-1035 10694553 1:CAS:528:DC%2BD3cXitVCgsLg%3D
9. RA Segal LC Goumnerova YK Kwon CD Stiles SL Pomeroy 1994 Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma Proc Natl Acad Sci U S A 91 12867-12871 7809137 1:CAS:528:DyaK2MXivVCqs7w%3D
10. MA Grotzer MD Hogarty AJ Janss X Liu H Zhao A Eggert LN Sutton LB Rorke GM Brodeur PC Phillips 2001 MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/ medulloblastoma Clin Cancer Res 7 2425-2433 11489822 1:CAS:528:DC%2BD3MXmsVOmtLs%3D
11. J Herms I Neidt B Luscher A Sommer P Schurmann T Schroder M Bergmann B Wilken S Probst-Cousin P Hernaiz-Driever J Behnke F Hanefeld T Pietsch HA Kretzschmar 2000 C-MYC expression in medulloblastoma and its prognostic value Int J Cancer 89 395-402 10.1002/ 1097-0215(20000920)89:5<395::AID-IJC1>3.3.CO;2-M 11008200 1:CAS:528:DC%2BD3cXnsFWmsro%3D
12. E Jaros J Lunec RH Perry PJ Kelly AD Pearson 1993 p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis Br J Cancer 68 801-807 8398711 1:STN:280:ByuD3c7kvVA%3D
13. AS Burns E Jaros M Cole R Perry AJ Pearson J Lunec 2002 The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system Br J Cancer 86 1117-1123 10.1038/sj.bjc.6600151 11953859 1:CAS:528:DC%2BD38XjvFGis7w%3D
14. TJ MacDonald KM Brown B LaFleur K Peterson C Lawlor Y Chen RJ Packer P Cogen DA Stephan 2001 Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease Nat Genet 29 143-152 10.1038/ng731 11544480 1:CAS:528:DC%2BD3MXnsFKgtb0%3D
15. SL Pomeroy P Tamayo M Gaasenbeek LM Sturla M Angelo ME McLaughlin JY Kim LC Goumnerova PM Black C Lau JC Allen D Zagzag JM Olson T Curran C Wetmore JA Biegel T Poggio S Mukherjee R Rifkin A Califano G Stolovitzky DN Louis JP Mesirov ES Lander TR Golub 2002 Prediction of central nervous system embryonal tumour outcome based on gene expression Nature 415 436-442 10.1038/415436a 11807556 1:CAS:528:DC%2BD38XhtVCqtr0%3D
16. I Vorechovsky O Tingby M Hartman B Stromberg M Nister VP Collins R Toftgard 1997 Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours Oncogene 15 361-366 9233770 1:CAS:528:DyaK2sXlt1Wjs7s%3D
17. M Wolter J Reifenberger C Sommer T Ruzicka G Reifenberger 1997 Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system Cancer Res 57 2581-2585 9205058 1:CAS:528:DyaK2sXkt12rtb8%3D
18. C Raffel RB Jenkins L Frederick D Hebrink B Alderete DW Fults CD James 1997 Sporadic medulloblastomas contain PTCH mutations Cancer Res 57 842-845 9041183 1:CAS:528:DyaK2sXhs1Kis7c%3D
19. H Huang BM Mahler-Araujo A Sankila L Chimelli Y Yonekawa P Kleihues H Ohgaki 2000 APC mutations in sporadic medulloblastomas Am J Pathol 156 433-437 10666372 1:CAS:528:DC%2BD3cXhtlGgurs%3D
20. MD Taylor L Liu C Raffel CC Hui TG Mainprize X Zhang R Agatep S Chiappa L Gao A Lowrance A Hao AM Goldstein T Stavrou SW Scherer WT Dura B Wainwright JA Squire JT Rutka D Hogg 2002 Mutations in SUFU predispose to medulloblastoma Nat Genet 31 306-310 10.1038/ng916 12068298 1:CAS:528:DC%2BD38XkvVGmtLY%3D
21. M Badiali A Pession G Basso L Andreini L Rigobello E Galassi F Giangaspero 1991 N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification Tumori 77 118-121 2048223 1:STN:280:By6B28zislc%3D
22. RJ Gilbertson AD Pearson RH Perry E Jaros PJ Kelly 1995 Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma Br J Cancer 71 473-477 7880726 1:STN:280:ByqC1cnjs1I%3D
23. MC Fruhwald MS O'Dorisio Z Dai SM Tanner DA Balster X Gao FA Wright C Plass 2001 Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas - implications for tumor biology and potential clinical utility Oncogene 20 5033-5042 11526488 1:CAS:528:DC%2BD3MXmtlCks7o%3D
24. ME Lusher JC Lindsey F Latif AD Pearson DW Ellison SC Clifford 2002 Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development Cancer Res 62 5906-5911 12384556 1:CAS:528:DC%2BD38XotFyktL0%3D
25. JC Lindsey ME Lusher JA Anderton S Bailey RJ Gilbertson AD Pearson DW Ellison SC Clifford 2004 Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling Carcinogenesis 25 661-668 14688019 1:CAS:528:DC%2BD2cXjsVekurw%3D Epub 2003 Dec 2019
26. DW Ellison SC Clifford A Gajjar RJ Gilbertson 2003 What's new in neuro-oncology? Recent advances in medulloblastoma Eur J Paediatr Neurol 7 53-66 10.1016/S1090-3798(03)00014-X 12697428
27. RE Taylor CC Bailey K Robinson CL Weston D Ellison J Ironside H Lucraft R Gilbertson DM Tait DA Walker BL Pizer J Imeson LS Lashford 2003 Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The international society of paediatric oncology/United Kingdom Children's Cancer Study Group PNET-3 Study J Clin Oncol 21 1581-1591 10.1200/JCO.2003.05.116 12697884 1:CAS:528:DC%2BD2cXptlCksLk%3D
28. D Strother D Ashley SJ Kellie A Patel D Jones-Wallace S Thompson R Heideman E Benaim R Krance L Bowman A Gajjar 2001 Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: Results of a collaborative study J Clin Oncol 19 2696-2704 11352962 1:CAS:528:DC%2BD3MXkt1Omu7s%3D
29. JG Paez PA Janne JC Lee S Tracy H Greulich S Gabriel P Herman FJ Kaye N Lindeman TJ Boggon K Naoki H Sasaki Y Fujii MJ Eck WR Sellers BE Johnson M Meyerson 2004 EGFR mutations in lung cancer: Correlation with clinical response to Gefitinib therapy Science 29 29
30. TJ Lynch DW Bell R Sordella S Gurubhagavatula RA Okimoto BW Brannigan PL Harris SM Haserlat JG Supko FG Haluska DN Louis DC Christiani J Settleman DA Haber 2004 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2129-2139 10.1056/NEJMoa040938 15118073 1:CAS:528:DC%2BD2cXktF2js7c%3D Epub 2004 Apr 2129
31. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57-70 10.1016/S0092-8674(00)81683-9 10647931 1:CAS:528:DC%2BD3cXks1CktA%3D%3D
32. JC Venter MD Adams EW Myers PW Li RJ Mural GG Sutton HO Smith M Yandell CA Evans RA Holt JD Gocayne P Amanatides RM Ballew DH Huson JR Wortman Q Zhang CD Kodira XH Zheng L Chen M Skupski G Subramanian PD Thomas J Zhang GL Gabor Miklos C Nelson S Broder AG Clark J Nadeau VA McKusick N Zinder AJ Levine RJ Roberts M Simon C Slayman M Hunkapiller R Bolanos A Delcher I Dew D Fasulo M Flanigan L Florea A Halpern S Hannenhalli S Kravitz S Levy C Mobarry K Reinert K Remington J Abu-Threideh E Beasley K Biddick V Bonazzi R Brandon M Cargill I Chandramouliswaran R Charlab K Chaturvedi Z Deng V Di Francesco P Dunn K Eilbeck C Evangelista AE Gabrielian W Gan W Ge F Gong Z Gu P Guan TJ Heiman ME Higgins RR Ji Z Ke KA Ketchum Z Lai Y Lei Z Li J Li Y Liang X Lin F Lu GV Merkulov N Milshina HM Moore AK Naik VA Narayan B Neelam D Nusskern DB Rusch S Salzberg W Shao B Shue J Sun Z Wang A Wang X Wang J Wang M Wei R Wides C Xiao et al 2001 The sequence of the human genome Science 291 1304-1351 10.1126/science.1058040 11181995 1:CAS:528:DC%2BD3MXhtlSgsbo%3D
33. S Ramaswamy TR Golub 2002 DNA microarrays in clinical oncology J Clin Oncol 20 1932-1941 11919254 1:CAS:528:DC%2BD38XjtFGqs78%3D
34. D Pinkel R Segraves D Sudar S Clark I Poole D Kowbel C Collins WL Kuo C Chen Y Zhai SH Dairkee BM Ljung JW Gray DG Albertson 1998 High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nat Genet 20 207-211 10.1038/2524 9771718 1:CAS:528:DyaK1cXms1eis7s%3D
35. EF Petricoin JL Hackett LJ Lesko RK Puri SI Gutman K Chumakov J Woodcock DW Feigal Jr. KC Zoon FD Sistare 2002 Medical applications of microarray technologies: A regulatory science perspective Nat Genet 32 474-479 10.1038/ng1029 12454641 1:CAS:528:DC%2BD38XovFyqs74%3D
36. L Liotta E Petricoin 2000 Molecular profiling of human cancer Nat Rev Genet 1 48-56 10.1038/35049567 11262874 1:CAS:528:DC%2BD3cXotlGls70%3D
37. RJ Gilbertson SC Clifford 2003 PDGFRB is overexpressed in metastatic medulloblastoma Nat Genet 35 197-198 10.1038/ng1103-197 14593398 1:CAS:528:DC%2BD3sXosFWrsLY%3D